Literature DB >> 17372191

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models.

Marzena J Fabis1, Gwen S Scott, Rhonda B Kean, Hilary Koprowski, D Craig Hooper.   

Abstract

Experimental allergic encephalomyelitis (EAE) is an inflammatory demyelinating disease of the CNS that is used to model certain parameters of multiple sclerosis. To establish the relative contributions of T cell reactivity, the loss of blood-brain barrier (BBB) integrity, CNS inflammation, and lesion formation toward the pathogenesis of EAE, we assessed the incidence of EAE and these parameters in mice lacking NF-kappaB, TNF-alpha, IFN-alphabeta receptors, IFN-gamma receptors, and inducible nitric oxide synthase. Although increased myelin oligodendrocyte glycoprotein-specific T cell reactivity was generally associated with a more rapid onset or increased disease severity, the loss of BBB integrity and cell accumulation in spinal cord tissues was invariably associated with the development of neurological disease signs. Histological and real-time RT-PCR analyses revealed differences in the nature of immune/inflammatory cell accumulation in the spinal cord tissues of the different mouse strains. On the other hand, disease severity during the acute phase of EAE directly correlated with the extent of BBB permeability. Thus, the loss of BBB integrity seems to be a requisite event in the development of EAE and can occur in the absence of important inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372191      PMCID: PMC1838442          DOI: 10.1073/pnas.0701252104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.

Authors:  D C Hooper; G S Scott; A Zborek; T Mikheeva; R B Kean; H Koprowski; S V Spitsin
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

2.  Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis.

Authors:  S Leibowitz; L Kennedy
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

3.  Experimental autoimmune encephalomyelitis. An anatomically-based explanation of clinical progression in rodents.

Authors:  R D Simmons; C C Bernard; G Singer; P R Carnegie
Journal:  J Neuroimmunol       Date:  1982-12       Impact factor: 3.478

4.  Interferon inhibitory activity in patients with multiple sclerosis.

Authors:  Kailash Chadha; Bianca Weinstock-Guttman; Robert Zivadinov; Kavitha Bhasi; Jason Muhitch; Joan Feichter; Miriam Tamaño-Blanco; Nadir Abdelrahman; Julian Ambrus; Frederick Munschauer; Murali Ramanathan
Journal:  Arch Neurol       Date:  2006-11

5.  Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis.

Authors:  Fahmy Aboul-Enein; Peter Weiser; Romana Höftberger; Hans Lassmann; Monika Bradl
Journal:  Acta Neuropathol       Date:  2006-04-25       Impact factor: 17.088

Review 6.  Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review.

Authors:  D O Willenborg; M A Staykova; W B Cowden
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

7.  Blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis: a correlative study between cerebrospinal fluid protein concentrations and tracer leakage in the central nervous system.

Authors:  K Kitz; H Lassmann; D Karcher; A Lowenthal
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus.

Authors:  J Chen; M Trounstine; F W Alt; F Young; C Kurahara; J F Loring; D Huszar
Journal:  Int Immunol       Date:  1993-06       Impact factor: 4.823

9.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; M Aguet; R M Zinkernagel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

View more
  35 in total

1.  Mast cells and the adaptive immune response.

Authors:  Melissa A Brown; Blayne A Sayed; Alison Christy
Journal:  J Clin Immunol       Date:  2008-09-19       Impact factor: 8.317

2.  Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction.

Authors:  Michael K Boettger; Andreas Weishaupt; Christian Geis; Klaus V Toyka; Claudia Sommer
Journal:  J Neural Transm (Vienna)       Date:  2009-11-28       Impact factor: 3.575

3.  Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.

Authors:  Min Jung Lee; Minhee Jang; Jonghee Choi; Byung Soo Chang; Do Young Kim; Sung-Hoon Kim; Yi-Seong Kwak; Seikwan Oh; Jong-Hwan Lee; Byung-Joon Chang; Seung-Yeol Nah; Ik-Hyun Cho
Journal:  Mol Neurobiol       Date:  2015-04-07       Impact factor: 5.590

4.  Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.

Authors:  Friederike Pfeiffer; Julia Schäfer; Ruth Lyck; Victoria Makrides; Sarah Brunner; Nicole Schaeren-Wiemers; Urban Deutsch; Britta Engelhardt
Journal:  Acta Neuropathol       Date:  2011-10-09       Impact factor: 17.088

5.  Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment.

Authors:  Graciela Andonegui; Erin L Zelinski; Courtney L Schubert; Derrice Knight; Laura A Craig; Brent W Winston; Simon C Spanswick; Björn Petri; Craig N Jenne; Janice C Sutherland; Rita Nguyen; Natalie Jayawardena; Margaret M Kelly; Christopher J Doig; Robert J Sutherland; Paul Kubes
Journal:  JCI Insight       Date:  2018-05-03

6.  Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells.

Authors:  Erika M Palmieri; Alessio Menga; Aurore Lebrun; Douglas C Hooper; D Allan Butterfield; Massimiliano Mazzone; Alessandra Castegna
Journal:  Antioxid Redox Signal       Date:  2016-11-02       Impact factor: 8.401

7.  Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.

Authors:  Yoshifumi Sonobe; Hideyuki Takeuchi; Kunio Kataoka; Hua Li; Shijie Jin; Maya Mimuro; Yoshio Hashizume; Yasuteru Sano; Takashi Kanda; Tetsuya Mizuno; Akio Suzumura
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

8.  Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Authors:  Marzena J Fabis; Timothy W Phares; Rhonda B Kean; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

9.  Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Authors:  Xiaomeng Ma; Ying Jiang; Aimin Wu; Xiaohong Chen; Rongbiao Pi; Mei Liu; Yingying Liu
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

10.  Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling.

Authors:  Suidong Ouyang; Hung Hsuchou; Abba J Kastin; Pramod K Mishra; Yuping Wang; Weihong Pan
Journal:  Brain Behav Immun       Date:  2014-02-24       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.